Recent 8-K filings for PLRX

Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.

• May 11, 2026 20:07 UTC earnings item 2.02item 9.01

  Pliant Therapeutics Q1 net loss $20M; doses first patient in Phase 1b FORTIFY trial

source · PLRX on sec.gov